litlas
ログインアカウント作成

William J. Sandborn

1992–2025 年に発表

別表記
William J Sandborn
575
論文数
149,746
被引用数
199
h 指数
568
i10 指数

被引用数

William J. Sandborn の年別被引用数1990 年: 被引用 3 件1991 年: 被引用 4 件1992 年: 被引用 2 件1993 年: 被引用 10 件1994 年: 被引用 4 件1995 年: 被引用 9 件1996 年: 被引用 15 件1997 年: 被引用 14 件1998 年: 被引用 27 件1999 年: 被引用 54 件2000 年: 被引用 78 件2001 年: 被引用 163 件2002 年: 被引用 210 件2003 年: 被引用 285 件2004 年: 被引用 384 件2005 年: 被引用 421 件2006 年: 被引用 575 件2007 年: 被引用 646 件2008 年: 被引用 826 件2009 年: 被引用 782 件2010 年: 被引用 940 件2011 年: 被引用 1,102 件2012 年: 被引用 914 件2013 年: 被引用 1,328 件2014 年: 被引用 1,336 件2015 年: 被引用 1,433 件2016 年: 被引用 1,352 件2017 年: 被引用 1,553 件2018 年: 被引用 1,540 件2019 年: 被引用 5,173 件2020 年: 被引用 5,481 件2021 年: 被引用 4,868 件2022 年: 被引用 4,460 件2023 年: 被引用 4,131 件2024 年: 被引用 6,029 件2025 年: 被引用 2,713 件2026 年: 被引用 64 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,646 件、この内訳の 21.8%中国: 引用元論文 2,745 件、この内訳の 9%イギリス: 引用元論文 2,192 件、この内訳の 7.2%イタリア: 引用元論文 1,771 件、この内訳の 5.8%カナダ: 引用元論文 1,768 件、この内訳の 5.8%ドイツ: 引用元論文 1,446 件、この内訳の 4.7%フランス: 引用元論文 1,405 件、この内訳の 4.6%オランダ: 引用元論文 1,121 件、この内訳の 3.7%スペイン: 引用元論文 935 件、この内訳の 3.1%ベルギー: 引用元論文 888 件、この内訳の 2.9%日本: 引用元論文 867 件、この内訳の 2.8%オーストラリア: 引用元論文 798 件、この内訳の 2.6%
0%21.8%その他 26%

機関

分野

  • Biochemistry, Genetics and Molecular Biology55.2%
  • Medicine30.7%
  • Immunology and Microbiology7.5%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Neuroscience1.1%
  • Nursing1%
  • その他3.3%

トピック

  • Inflammatory Bowel Disease18.7%
  • Microscopic Colitis6.3%
  • Gut microbiota and health4.2%
  • Rheumatoid Arthritis Research and Therapies3.3%
  • Autoimmune and Inflammatory Disorders2.6%
  • Biosimilars and Bioanalytical Methods1.7%
  • その他63.2%

共著者

全論文

検索で開く
  1. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    著者: Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem A. Bemelman, Silvio Danese, Jean Yves Mary, David T. Rubin, Jean‐Frédéric Colombel, Laurent Peyrin‐Biroulet, Iris Dotan, María T. Abreu, Axel Dignaß - Gastroenterology 2021 被引用: 2,666

  2. Ulcerative colitis

    著者: Íngrid Ordás, Lars Eckmann, Mark A. Talamini, Daniel C. Baumgart, William J. Sandborn - The Lancet 2012 被引用: 2,061

  3. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel, William J. Sandborn, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,852

  4. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Chinyu Su, Bruce E. Sands, Geert D’Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G. Feagan, Walter Reinisch, Wojciech Niezychowski, Gary S. Friedman, Nervin Lawendy, Dahong Yu, Deborah Woodworth, Arnab Mukherjee, Haiying Zhang, Paul J. Healey, Julián Panés - New England Journal of Medicine 2017 被引用: 1,727

  5. Global chemical effects of the microbiome include new bile-acid conjugations

    著者: Robert A. Quinn, Alexey V. Melnik, Alison Vrbanac, Ting Fu, Kathryn A. Patras, Mitchell P. Christy, Zsolt Bodai, Pedro Belda‐Ferre, Anupriya Tripathi, Lawton K. Chung, Michael Downes, Ryan D. Welch, Melissa A. Quinn, Greg Humphrey, Morgan Panitchpakdi, Kelly C. Weldon, Alexander A. Aksenov, Ricardo Silva, Julián Ávila-Pacheco, Clary B. Clish, Sena Bae, Himel Mallick, Eric A. Franzosa, Jason Lloyd‐Price, Robert H. Bussell, Taren Thron, Andrew T. Nelson, Mingxun Wang, Eric C. Leszczynski, Fernando Vargas, Julia M. Gauglitz, Michael J. Meehan, Emily C. Gentry, Timothy D. Arthur, Alexis C. Komor, Orit Poulsen, Brigid S. Boland, John T. Chang, William J. Sandborn, Meerana Lim, Neha Garg, Julie C. Lumeng, Ramnik J. Xavier, Barbara I. Kazmierczak, Ruchi Jain, Marie E. Egan, Kyung E. Rhee, David P. Ferguson, Manuela Raffatellu, Hera Vlamakis, Gabriel G. Haddad, Dionicio Siegel, Curtis Huttenhower, Sarkis K. Mazmanian, Ronald M. Evans, Victor Nizet, Rob Knight, Pieter C. Dorrestein - Nature 2020 被引用: 600

  6. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Bruce E. Sands, William J. Sandborn, Remo Panaccione, Christopher D. O’Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J. Adedokun, Katherine Li, Laurent Peyrin‐Biroulet, Gert Van Assche, Silvio Danese, Stephan R. Targan, María T. Abreu, Tadakazu Hisamatsu, Philippe Szapary, Colleen Marano - New England Journal of Medicine 2019 被引用: 1,180

  7. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

    著者: Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L. Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D’Haens, Hiroshi Nakase, Julián Panés, Peter Higgins, Pascal Juillerat, James O. Lindsay, Edward V. Loftus, William J. Sandborn, Walter Reinisch, Minhu Chen, Yuri Sánchez González, Bidan Huang, Wangang Xie, John Liu, Michael Weinreich, Remo Panaccione - The Lancet 2022 被引用: 597

  8. Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

    著者: Brian G. Feagan, William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion Blank, Jewel Johanns, Long-Long Gao, Miao Ye, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B. Hanauer, Séverine Vermeire, Stephan R. Targan, Subrata Ghosh, Willem J. de Villiers, Jean–Frédéric Colombel, Zsolt Tulassay, Ursula Seidler, Bruce Salzberg, Pierre Desreumaux, Scott D. Lee, Edward V. Loftus, Levinus A. Dieleman, Seymour Katz, Paul Rutgeerts - New England Journal of Medicine 2016 被引用: 1,806

  9. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    著者: William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, Stephen B. Hanauer, Jean‐Frédéric Colombel, Bruce E. Sands, Milan Lukáš, Richard N. Fedorak, Scott Lee, Brian Bressler, Irving H. Fox, Maria Rosario, Serap Sankoh, Jing Xu, Kristin Stephens, Catherine Milch, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,687

  10. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity

    著者: Robert H. Mills, Parambir S. Dulai, Yoshiki Vázquez‐Baeza, Consuelo Sauceda, Noëmie Daniel, Romana R. Gerner, Lakshmi E. Batachari, Mario Malfavon, Qiyun Zhu, Kelly C. Weldon, Greg Humphrey, Marvic Carrillo-Terrazas, Lindsay DeRight Goldasich, MacKenzie Bryant, Manuela Raffatellu, Robert A. Quinn, Andrew T. Gewirtz, Benoît Chassaing, Hiutung Chu, William J. Sandborn, Pieter C. Dorrestein, Rob Knight, David J. Gonzalez - Nature Microbiology 2022 被引用: 385

  11. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Paul Rutgeerts, William J. Sandborn, Brian G. Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Daniel H. Present, Bruce E. Sands, Jean‐Frédéric Colombel - New England Journal of Medicine 2005 被引用: 3,883

  12. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    著者: William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet, Marla C. Dubinsky, Julián Panés, Andrés Yarur, Timothy E. Ritter, Filip Baert, Stefan Schreiber, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J. Rabbat, Michael Chiorean, Douglas C. Wolf, Bruce E. Sands, Geert D’Haens, Silvio Danese, Martina Goetsch, Brian G. Feagan - The Lancet 2023 被引用: 333

  13. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

    著者: Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D’Haens, Robert H. Diamond, Delma L. Broussard, Kezhen L. Tang, C. Janneke van der Woude, Paul Rutgeerts - New England Journal of Medicine 2010 被引用: 3,108

  14. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Geert D’Haens, Douglas C. Wolf, Igor Jovanović, Stephen B. Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y. Hua, Ji Hwan Lee, Lorna Charles, Denesh K. Chitkara, Keith Usiskin, Jean–Frédéric Colombel, Loren Laine, Silvio Danese - New England Journal of Medicine 2021 被引用: 532

  15. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    著者: Geert D’Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Marc Ferrante - The Lancet 2022 被引用: 387

  16. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    著者: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 被引用: 1,838

  17. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Geert D’Haens, Marla C. Dubinsky, Taku Kobayashi, Peter M. Irving, Stefanie Howaldt, Juris Pokrotnieks, Kathryn A. Krueger, Janelle Laskowski, Xingyuan Li, Trevor Lissoos, Joe Milata, Nathan Morris, Vipin Arora, Catherine Milch, William J. Sandborn, Bruce E. Sands - New England Journal of Medicine 2023 被引用: 317

  18. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    著者: Brian G. Feagan, Silvio Danese, Edward V. Loftus, Séverine Vermeire, Stefan Schreiber, Timothy E. Ritter, Ronald Fogel, Rajiv Mehta, Sandeep Nijhawan, Radosław Kempiński, Rafał Filip, Ihor Hospodarskyy, Ursula Seidler, Frank Seibold, Ian Beales, Hyo Jong Kim, John McNally, Chohee Yun, Sally Zhao, Xiaopeng Liu, Chia‐Hsiang Hsueh, Chantal Tasset, R. Besuyen, Mamoru Watanabe, William J. Sandborn, Gerhard Rogler, Toshifumi Hibi∥, Laurent Peyrin‐Biroulet - The Lancet 2021 被引用: 437

  19. Crohn's disease

    著者: Daniel C. Baumgart, William J. Sandborn - The Lancet 2012 被引用: 2,113

  20. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    著者: Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukáš, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Méndez, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens - The Lancet 2017 被引用: 912

  21. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    著者: Marc Ferrante, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Geert D’Haens - The Lancet 2022 被引用: 316

  22. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

    著者: Brian G. Feagan, Bruce E. Sands, William J. Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés, Tkachev Av, Dilara Kalimullina, Robert Petryka, М. Ф. Осипенко, Nataliia Tsarynna, Leonid Bilіanskyi, D Kleczkowski, Andrii Yurkiv, Marek Woynarowski, О. Аbrahamovych, Olha Ivanishyn, Grażyna Rydzewska, Jarosław Kierkuś, Elina Petrova, Olga Vasilevskaya, Halyna Afanasieva, Carlos Fernando de Magalhães Francesconi, Jarosław Leszczyszyn, Elena Bunkova, Dmitry Platonov, Olena Datsenko, Oleksii Gridnyev, Ihor Hospodarsky, Liudmyla Nykodymivna Prystupa, Mykola Stanislavchuk, Anatoly Pershko, О. Б. Щукина, В. И. Симаненков, Oleksandr Golovchenko, William Holderman, Juan S. Lasa, Jakob Begun, Maria de Lourdes de Abreu Ferrari, Pedro López, A. A. Obrezan, Shiraz Farooq, Felix Tiongco, Abel Novillo, Emiliano Tron, Finlay Macrae, Rupert W. Leong, Lígia Yukie Sassaki, Cyrla Zaltman, Roberto Luiz Kaiser, Andreas Stallmach, Jochen Klaus, Manuel Martı́nez, Azalia Ruiz, Р А Абдулхаков, Vishvinder Sharma, Louis Y Korman, James D. Lord, Bhaktasharan Patel, Timothy E. Ritter - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 224

  23. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

    著者: Bram Verstockt, Azucena Salas, Bruce E. Sands, Clara Abraham, Haim Leibovitzh, Markus F. Neurath, Niels Vande Casteele, Silvio Danese, Geert D’Haens, Lars Eckmann, William A. Faubion, Brian G. Feagan, Vipul Jairath, Christopher Ma, Saurabh Mehandru, Julián Panés, Florian Rieder, William J. Sandborn, Mark S. Silverberg, Marisol Veny, Séverine Vermeire, Stefania Vetrano - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 231

  24. Inflammatory bowel disease: clinical aspects and established and evolving therapies

    著者: Daniel C. Baumgart, William J. Sandborn - The Lancet 2007 被引用: 1,933